These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27573059)

  • 1. In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy.
    Marcu LG; Marcu D
    Sci Rep; 2016 Aug; 6():32332. PubMed ID: 27573059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.
    Marcu LG; Marcu D
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28857306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.
    Marcu LG; Marcu D; Filip SM
    Cell Prolif; 2016 Jun; 49(3):304-14. PubMed ID: 27079860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hypofractionated radiotherapy in the management of head and neck cancer - a modelling approach.
    Marcu LG; Marcu D
    J Theor Biol; 2019 Dec; 482():109998. PubMed ID: 31493484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway.
    Lim YC; Kang HJ; Kim YS; Choi EC
    Eur J Cancer; 2012 Nov; 48(17):3310-8. PubMed ID: 22640830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer.
    Marcu LG; Bezak E
    Cell Prolif; 2012 Oct; 45(5):404-12. PubMed ID: 22775509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer.
    Tuckwell W; Bezak E; Yeoh E; Marcu L
    Phys Med Biol; 2008 Sep; 53(17):4489-507. PubMed ID: 18677039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
    Harriss-Phillips WM; Bezak E; Yeoh EK
    Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
    Kidwai F; Costea DE; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Head Neck; 2012 Jun; 34(6):894-9. PubMed ID: 21850700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
    Zeng WG; Hu P; Wang JN; Liu RB
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
    Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
    Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
    Lim YC; Oh SY; Kim H
    Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.
    Duarte S; Loubat A; Momier D; Topi M; Faneca H; Pedroso de Lima MC; Carle GF; Pierrefite-Carle V
    Oncol Rep; 2012 Sep; 28(3):1057-62. PubMed ID: 22825753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
    Kaseb HO; Lewis DW; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells in head and neck squamous cell carcinoma.
    Ailles L; Prince M
    Methods Mol Biol; 2009; 568():175-93. PubMed ID: 19582427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.